Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid leukemia (ND AML): Updated results from a phase 1 study.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Roboz, GJ; Dinardo, CD; Stein, EM; de Botton, S; Mims, AS; Prince, GT; Altman, JK; Arellano, ML; Erba, HP; Pollyea, DA; Stein, AS; Watts, JM; Fathi, AT; Kantarjian, HM; Tallman, MS; Fan, B; Liu, H; Wu, B; Attar, EC; Stone, RM

Published Date

  • May 20, 2019

Published In

Volume / Issue

  • 37 / 15

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • May 31, 2019

Conference End Date

  • June 4, 2019